Malignant mesothelioma: ultrastructural distinction from adenocarcinoma
- PMID: 6287872
Malignant mesothelioma: ultrastructural distinction from adenocarcinoma
Abstract
Mesotheliomas and metastatic adenocarcinomas involving the pleura are frequently difficult to distinguish by light-microscopic and histochemical methods. In a double-blind study, we have compared ultrastructural features of 10 mesotheliomas of epithelial type and 10 adenocarcinomas from the lung, breast, and upper GI tract, i.e., sites known to give rise to metastases which mimic mesothelioma. Mesotheliomas were observed to have a significantly greater microvillus length/diameter ratio (LDR) than adenocarcinomas (p less than 0.01) and more abundant intermediate filaments (p less than 0.001). Mesotheliomas had more complex microvilli than adenocarcinomas, whereas adenocarcinomas had rootlets (2/10 cases) and lamellar inclusion bodies (2/10 cases), both of which were absent in the mesotheliomas. This study provides quantitative and qualitative ultrastructural features of potential utility in the differential diagnosis of pleural mesotheliomas and adenocarcinomas.
Similar articles
-
Scanning electron microscopic distinction of pleural mesotheliomas from adenocarcinomas.Mod Pathol. 1993 Nov;6(6):761-4. Mod Pathol. 1993. PMID: 8302820
-
The distinction of mesothelioma from adenocarcinoma in malignant effusions by electron microscopy.Acta Cytol. 1985 May-Jun;29(3):219-25. Acta Cytol. 1985. PMID: 3859121
-
The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.Diagn Cytopathol. 2005 Mar;32(3):137-44. doi: 10.1002/dc.20200. Diagn Cytopathol. 2005. PMID: 15690333
-
The ultrastructural pathology of malignant pleural mesothelioma.Pathol Annu. 1989;24 Pt 1:303-53. Pathol Annu. 1989. PMID: 2654842 Review. No abstract available.
-
Value of the Ber-EP4 antibody in differentiating epithelial pleural mesothelioma from adenocarcinoma. The M.D. Anderson experience and a critical review of the literature.Am J Clin Pathol. 1998 Jan;109(1):85-9. doi: 10.1093/ajcp/109.1.85. Am J Clin Pathol. 1998. PMID: 9426522 Review.
Cited by
-
Demonstration of keratin in human adenocarcinomas.Am J Pathol. 1983 May;111(2):213-23. Am J Pathol. 1983. PMID: 6189402 Free PMC article.
-
The ultrastructural localization of keratin proteins and carcinoembryonic antigen in malignant mesotheliomas.Am J Pathol. 1984 Sep;116(3):385-90. Am J Pathol. 1984. PMID: 6206729 Free PMC article.
-
Malignant mesotheliomas. Improved differential diagnosis from lung adenocarcinomas using monoclonal antibodies 44-3A6 and 624A12.Am J Pathol. 1986 Jun;123(3):497-507. Am J Pathol. 1986. PMID: 3717302 Free PMC article.
-
Molecular cloning of a cell-surface glycoprotein that can potentially discriminate mesothelium from epithelium: its identification as vascular cell adhesion molecule 1.Br J Cancer. 1995 Mar;71(3):562-70. doi: 10.1038/bjc.1995.110. Br J Cancer. 1995. PMID: 7533516 Free PMC article.
-
The intermediate filament cytoskeleton of malignant mesotheliomas and its diagnostic significance.Am J Pathol. 1985 Nov;121(2):235-47. Am J Pathol. 1985. PMID: 2414994 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical